Literature DB >> 20665039

[Genetic background of juvenile idiopathic arthritis].

J P Haas1.   

Abstract

Several genetic factors have recently been observed as having an influence on susceptibility, course and prognosis of juvenile idiopathic arthritis (JIA): 1. Affected sib pairs were observed to have a low concordance in terms of disease incidence, but significant concordance in terms of subtype and course of disease. 2. Each subtype of JIA was observed to have a distinct genetic background. 3. Some JIA patients do not carry any of the defined risk genes. 4. Most subtypes of JIA have a distinct different genetic background to rheumatoid arthritis in adults. 5. Multiple factors have been observed to be involved in pathogenesis implying genetic and environmental factors. 6. Systemic JIA differs from all other subtypes in terms of genetic background and treatment options. It is currently assumed to be an autoinflammatory disease. 7. Genetic factors not only affect the course of the disease, but also response and complication rate. Increasing knowledge on the factors involved in the pathogenesis of JIA as well as analysis of large patient cohorts in consortiums cooperating on an international level have helped define many important polymorphisms; these are currently the subject of further investigation.

Entities:  

Mesh:

Year:  2010        PMID: 20665039     DOI: 10.1007/s00393-010-0632-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  64 in total

1.  The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27.

Authors:  F McGarry; R Walker; R Sturrock; M Field
Journal:  J Rheumatol       Date:  1999-05       Impact factor: 4.666

2.  Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis.

Authors:  Rebecca Lamb; Wendy Thomson; Emma Ogilvie; Rachelle Donn
Journal:  Arthritis Rheum       Date:  2005-11

3.  Immunogenetics of juvenile chronic arthritis. I. HLA interaction between A2, DR5/8-DR/DQ, and DPB1*0201 is a general feature of all subsets of early onset pauciarticular juvenile chronic arthritis II. DPB1 polymorphism plays a role in systemic juvenile chronic arthritis.

Authors:  C Paul; Z Yao; C Nevinny-Stickel; E Keller; U Schoenwald; H Truckenbrodt; J Hoza; H J Suschke; E D Albert
Journal:  Tissue Antigens       Date:  1995-04

4.  Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis.

Authors:  J P Haas; C Nevinny-Stickel; U Schoenwald; H Truckenbrodt; J Suschke; E D Albert
Journal:  Hum Immunol       Date:  1994-11       Impact factor: 2.850

5.  Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations.

Authors:  Kiem Oen; Peter N Malleson; David A Cabral; Alan M Rosenberg; Ross E Petty; Martin Reed; Marlis L Schroeder; Mary Cheang
Journal:  J Rheumatol       Date:  2003-03       Impact factor: 4.666

6.  HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis.

Authors:  Lillemor Berntson; Michael Damgård; Boel Andersson-Gäre; Troels Herlin; Susan Nielsen; Ellen Nordal; Marite Rygg; Marek Zak; Anders Fasth
Journal:  J Rheumatol       Date:  2008-09-01       Impact factor: 4.666

Review 7.  Spondyloarthropathies and psoriatic arthritis in children.

Authors:  R Burgos-Vargas
Journal:  Curr Opin Rheumatol       Date:  1993-09       Impact factor: 5.006

Review 8.  How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets.

Authors:  Virginia Pascual; Florence Allantaz; Pinakeen Patel; A Karolina Palucka; Damien Chaussabel; Jacques Banchereau
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

9.  Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis.

Authors:  Ana Filipa Mourão; Joana Caetano-Lopes; Paula Costa; Helena Canhão; Maria José Santos; Patrícia Pinto; Iva Brito; Paulo Nicola; João Cavaleiro; José Teles; Artur Sousa; José Melo Gomes; Jaime Branco; José Teixeira da Costa; João Gomes Pedro; Mário Viana de Queiroz; João Eurico Fonseca
Journal:  J Rheumatol       Date:  2009-01-22       Impact factor: 4.666

10.  HLA antigens in juvenile arthritis. Genetic basis for the different subtypes.

Authors:  O Førre; J H Dobloug; H M Høyeraal; E Thorsby
Journal:  Arthritis Rheum       Date:  1983-01
View more
  2 in total

1.  [B-cell targeted therapy for children and adolescents with rheumatic diseases].

Authors:  H Morbach; H J Girschick
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

2.  [Transitional care in rheumatology in Germany].

Authors:  S Schalm; A F Jansson
Journal:  Internist (Berl)       Date:  2012-09       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.